The global Tigecycline market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Tigecycline volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tigecycline market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Pfizer
Hisun Pharma
Hansoh Pharma
Jiagsu Aosaikang Pharmaceutical
HICIN Pharma
Abbott Laboratories
Amgen
Astrazeneca
Merck
Novartis
Roche Holdings
Johnson & Johnson
Sanofi
Lifecare Innovations
Progen Nutraceuticals

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Gram Positive Bacteria
Gram Negative Bacteria

Segment by Application
Skin & Soft Tissue Infections
Complicated Intra-abdominal Infections
Community-acquired Bacterial Pneumonia